Assignee
INCOZEN THERAPEUTICS PVT LTD
IN·5 granted patents·3 pending applications·49 citations·filing 2013–2023
Top patents by PatentIndex Score
8 records- 0195US9649302B2Methods of treating autoimmune, respiratory and inflammatory disorders by inhalation of roflumilast N-oxideINCOZEN THERAPEUTICS PVT LTD·Filed 2014·Granted May 16, 2017·29 cites·16 claims
- 0292US8912331B23,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of protein kinasesINCOZEN THERAPEUTICS PVT LTD·Filed 2013·Granted Dec 16, 2014·17 cites·28 claims
- 0384US10087182B23,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of protein kinasesINCOZEN THERAPEUTICS PVT LTD·Filed 2017·Granted Oct 2, 2018·3 cites·9 claims
- 0469US2022008400A1Methods of treating autoimmune, respiratory and inflammatory disorders by inhalation of roflumilast n-oxideINCOZEN THERAPEUTICS PVT LTD·Filed 2021·Application pending·0 cites
- 0567US11103488B2Methods of treating autoimmune, respiratory and inflammatory disorders by inhalation of roflumilast N-oxideINCOZEN THERAPEUTICS PVT LTD·Filed 2017·Granted Aug 31, 2021·0 cites·25 claims
- 0665US2025241923A1A dual selective pi3k delta and gamma inhibitors and/or a salt-inducible kinase 3 inhibitor for treating solid tumorsINCOZEN THERAPEUTICS PVT LTD·Filed 2023·Application pending·0 cites
- 0764US10590129B23,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of protein kinasesINCOZEN THERAPEUTICS PVT LTD·Filed 2018·Granted Mar 17, 2020·0 cites·9 claims
- 0864US2015133449A1Novel 3,5-disubstituted-3h-imidazo[4,5-b]pyridine and 3,5-disubstituted -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of protein kinasesINCOZEN THERAPEUTICS PVT LTD·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when INCOZEN THERAPEUTICS PVT LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →